Veeva Systems Inc.

VEEV

US9224751084

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 16:00:02 2025-02-06 EST			5-day change	1st Jan Change
239.43 ^USD	+0.06%		+1.00%	+13.88%

02-04	Servier to Adopt Veeva RIM to Streamline and Advance its Global Regulatory Operations	CI
02-03	DNAnexus Expands Relationship with Veeva to Advance Global Regulatory Collaboration	CI

Morgan Stanley Adjusts Price Target on Veeva Systems to $195 From $183

December 17, 2024 at 10:16 am

This article is reserved for members

Already a member?

Not a member ?

Free registration

Latest news about Veeva Systems Inc.

Servier to Adopt Veeva RIM to Streamline and Advance its Global Regulatory Operations	02-04	CI
DNAnexus Expands Relationship with Veeva to Advance Global Regulatory Collaboration	02-03	CI
Veeva Systems Shares Fall After Downgrade From Goldman Sachs	01-23	MT
Project Stargate: Trump's AI adventure questions Musk's motives	01-23
Goldman Sachs Downgrades Veeva Systems to Sell From Buy, Cuts Price Target to $200 From $261	01-23	MT
Analyst recommendations: Netflix, Block, Kinder Morgan, EA, Firstgroup...	01-23
Veeva Systems Seeks M&A	01-16	CI
Veeva Systems Inc. Presents at 27th Annual Needham Growth Conference, Jan-16-2025 01:30 PM	01-16
KeyBanc Cuts Price Target on Veeva Systems to $255 From $285, Keeps Overweight Rating	01-08	MT
Stephens Initiates Coverage on Veeva Systems With Overweight Rating, $280 Price Target	12-20	MT
Health-care Sector Faces Mixed Prospects in 2025, Morgan Stanley Says	12-17	MT
Morgan Stanley Adjusts Price Target on Veeva Systems to $195 From $183	12-17	MT
Veeva Systems Inc. Presents at Raymond James 2024 TMT & Consumer Conference, Dec-11-2024 10:40 AM	12-11
Veeva Systems Insider Sold Shares Worth $390,128, According to a Recent SEC Filing	12-06	MT
KeyBanc Raises Veeva Systems Price Target to $285 From $240, Maintains Overweight Rating	12-06	MT
Truist Securities Ups Price Target on Veeva Systems to $261 From $207, Keeps Hold Rating	12-06	MT
Will the strong economy be a brake on further rate cuts?	12-06
Sector Update: Health Care Stocks Edge Higher Premarket Friday	12-06	MT
Sector Update: Health Care	12-06	MT
UBS Raises Price Target on Veeva Systems to $250 From $245, Keeps Neutral Rating	12-06	MT
RBC Raises Price Target on Veeva Systems to $285 From $275, Keeps Outperform Rating	12-06	MT
Veeva Systems Fiscal Q3 Non-GAAP Earnings, Sales Rise; Lifts Full-Year Guidance; Shares Advance Premarket	12-06	MT
Analyst recommendations: Applovin, Delta Air Lines, Docusign, Salesforce, Halma...	12-06
Veeva Systems Inc., Q3 2025 Earnings Call, Dec 05, 2024	12-05
Veeva Systems Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Fiscal Year Outlook Raised	12-05	MT

Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. The Company offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and their strategic business functions from research and development (R&D) through commercialization. The Companyâs three product categories: Veeva Development Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Vault Clinical advances clinical trial execution by providing a complete and connected technology ecosystem. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Its software offerings include Veeva CRM, Veeva Vault PromoMats, Veeva Vault Medical, and Veeva Crossix. Its data offerings include Veeva OpenData, Veeva Link, and Veeva Compass.

Employees

7,172

Sector

Advanced Medical Equipment & Technology

Calendar

2025-03-03 - Q4 2025 Earnings Release (Projected)

More about the company